2 assets in Rheumatic Heart Disease

Therapeutic assets addressing Rheumatic Heart Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Rivaroxaban Rheumatic Heart Disease	Population Health Research Institute	P3	BB (64)
Aspirin Rheumatic Heart Disease	Population Health Research Institute	P3	B (60)